<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://insider.thefdagroup.com/p/guidance-breakdown-fda-formalizes-cmc-for-cell-and-gene-therapy</loc><news:news><news:publication><news:name>The FDA Group's Insider Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-06T16:31:31+00:00</news:publication_date><news:title>Guidance Breakdown: FDA Formalizes CMC Flexibilities for Cell and Gene Therapy Products Heading Toward BLA</news:title></news:news></url><url><loc>https://insider.thefdagroup.com/p/clinical-operations-efficiency</loc><news:news><news:publication><news:name>The FDA Group's Insider Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-05T18:34:12+00:00</news:publication_date><news:title>How Contracted Insourcing is Making Clinical Operations More Efficient</news:title></news:news></url></urlset>